Budget Amount *help |
¥3,770,000 (Direct Cost: ¥2,900,000、Indirect Cost: ¥870,000)
Fiscal Year 2015: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Fiscal Year 2014: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
Outline of Final Research Achievements |
Bullous pemphigoid (BP) is an autoimmune subepidermal blistering disease associated with autoantibodies to type XVII collagen (COL17). When keratinocytes are treated with BP-IgG, COL17 internalizes into cells by way of the macropinocytosis pathway. The inhibition of small GTPase family members Rac1 and Cdc42 was found to strongly repress COL17 internalization; additionally the Rho inhibitor also partially blocked the internalization.This depletion of COL17 from lateral-apical plasma membrane generates a significant shortage of COL17-supplementation to hemidesmosome, resulting in the formation of incomplete hemidesmsome lacking COL17.
|